Literature DB >> 16232302

Role of Apaf-1, a key regulator of apoptosis, in melanoma progression and chemoresistance.

Mara Campioni1, Daniele Santini, Giuseppe Tonini, Raffaele Murace, Emanuele Dragonetti, Enrico P Spugnini, Alfonso Baldi.   

Abstract

Apoptosis protease-activating factor-1 (Apaf-1) is a key regulator of the mitochondrial apoptotic pathway, being the central element of the multimeric apoptosome formed by procaspase 9, cytochrome c, and Apaf-1 itself. In this review, the principal aspects about Apaf-1 gene structure and function, and its role in the apoptotic machinery, are described. Moreover, the most recent findings about the involvement of this molecule in melanoma progression and chemoresistance, as well as the clinico-pathological relevance of these findings in the treatment of this deadly disease, are reported.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16232302     DOI: 10.1111/j.1600-0625.2005.00360.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  17 in total

1.  Upregulation of microRNA-23a regulates proliferation and apoptosis by targeting APAF-1 in laryngeal carcinoma.

Authors:  Xiao-Wen Zhang; Ning Liu; Sheng Chen; Y E Wang; Kai-Lai Sun; Zhen-Ming Xu; Wei-Neng Fu
Journal:  Oncol Lett       Date:  2015-05-20       Impact factor: 2.967

2.  Systematic Epigenomic Analysis Reveals Chromatin States Associated with Melanoma Progression.

Authors:  Petko Fiziev; Kadir C Akdemir; John P Miller; Emily Z Keung; Neha S Samant; Sneha Sharma; Christopher A Natale; Christopher J Terranova; Mayinuer Maitituoheti; Samirkumar B Amin; Emmanuel Martinez-Ledesma; Mayura Dhamdhere; Jacob B Axelrad; Amiksha Shah; Christine S Cheng; Harshad Mahadeshwar; Sahil Seth; Michelle C Barton; Alexei Protopopov; Kenneth Y Tsai; Michael A Davies; Benjamin A Garcia; Ido Amit; Lynda Chin; Jason Ernst; Kunal Rai
Journal:  Cell Rep       Date:  2017-04-25       Impact factor: 9.423

3.  Loss of APAF-1 expression is associated with early recurrence in stage I, II, and III colorectal cancer.

Authors:  Byung Kyu Ahn; Sung Hoo Kim; Seung Sam Paik; Kang Hong Lee
Journal:  Langenbecks Arch Surg       Date:  2016-08-02       Impact factor: 3.445

Review 4.  Melanoma resistance to photodynamic therapy: new insights.

Authors:  Ying-Ying Huang; Daniela Vecchio; Pinar Avci; Rui Yin; Maria Garcia-Diaz; Michael R Hamblin
Journal:  Biol Chem       Date:  2013-02       Impact factor: 3.915

Review 5.  MicroRNA in pancreatic cancer.

Authors:  Keiichi Yonemori; Hiroshi Kurahara; Kosei Maemura; Shoji Natsugoe
Journal:  J Hum Genet       Date:  2016-06-02       Impact factor: 3.172

Review 6.  MiR-21: an environmental driver of malignant melanoma?

Authors:  Bodo C Melnik
Journal:  J Transl Med       Date:  2015-06-27       Impact factor: 5.531

7.  The role of apoptosis in the pathology of pancreatic cancer.

Authors:  Nicole Samm; Kristin Werner; Felix Rückert; Hans Detlev Saeger; Robert Grützmann; Christian Pilarsky
Journal:  Cancers (Basel)       Date:  2010-12-23       Impact factor: 6.639

8.  Interaction of translationally controlled tumor protein with Apaf-1 is involved in the development of chemoresistance in HeLa cells.

Authors:  Jaehoon Jung; Hyo Young Kim; Jeehye Maeng; Moonhee Kim; Dong Hae Shin; Kyunglim Lee
Journal:  BMC Cancer       Date:  2014-03-07       Impact factor: 4.430

9.  Tumor necrosis is associated with increased alphavbeta3 integrin expression and poor prognosis in nodular cutaneous melanomas.

Authors:  Ingeborg M Bachmann; Rita G Ladstein; Oddbjørn Straume; George N Naumov; Lars A Akslen
Journal:  BMC Cancer       Date:  2008-12-05       Impact factor: 4.430

10.  Automated dermoscopy image analysis of pigmented skin lesions.

Authors:  Alfonso Baldi; Marco Quartulli; Raffaele Murace; Emanuele Dragonetti; Mario Manganaro; Oscar Guerra; Stefano Bizzi
Journal:  Cancers (Basel)       Date:  2010-03-26       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.